Mano, Max S.
Oliveira, Leandro Jonata C.
Hanna, Samir A.
Article History
Accepted: 5 March 2021
First Online: 26 March 2021
Declarations
:
: • Dr. Mano has provided compensated consultancy services and lectures for Roche, MSD, Astrazeneca, Novartis, Lilly-Inclone, and Pfizer though none are related to the subject of this article.• Dr. Hanna has provided compensated lecture services for Roche.• Dr. Oliveira has no conflicts of interest to report.
: This article does not contain any studies with human or animal subjects performed by the authors.